Invesco’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-237,294
| Closed | -$6.42M | – | 3916 |
|
|
2024
Q2 | $6.42M | Sell |
237,294
-29,510
| -11% | -$614K | ﹤0.01% | 2056 |
|
|
2024
Q1 | $4.89M | Buy |
266,804
+247,196
| +1,261% | +$3.92M | ﹤0.01% | 2254 |
|
|
2023
Q4 | $241K | Sell |
19,608
-3,440
| -15% | -$32.3K | ﹤0.01% | 3504 |
|
|
2023
Q3 | $345K | Buy |
23,048
+2,648
| +13% | +$55.1K | ﹤0.01% | 3381 |
|
|
2023
Q2 | $663K | Sell |
20,400
-521,837
| -96% | -$19.1M | ﹤0.01% | 3101 |
|
|
2023
Q1 | $21.2M | Buy |
542,237
+25,460
| +5% | +$1.25M | 0.01% | 1321 |
|
|
2022
Q4 | $27.3M | Buy |
516,777
+501,029
| +3,182% | +$24.4M | 0.01% | 1206 |
|
|
2022
Q3 | $709K | Buy |
15,748
+1,791
| +13% | +$77K | ﹤0.01% | 3063 |
|
|
2022
Q2 | $509K | Sell |
13,957
-473
| -3% | -$17.2K | ﹤0.01% | 3319 |
|
|
2022
Q1 | $595K | Sell |
14,430
-267
| -2% | -$9.4K | ﹤0.01% | 3306 |
|
|
2021
Q4 | $626K | Sell |
14,697
-95
| -0.6% | -$4.75K | ﹤0.01% | 3291 |
|
|
2021
Q3 | $814K | Buy |
14,792
+2,756
| +23% | +$144K | ﹤0.01% | 3203 |
|
|
2021
Q2 | $576K | Sell |
12,036
-431,091
| -97% | -$22M | ﹤0.01% | 3351 |
|
|
2021
Q1 | $22.4M | Sell |
443,127
-390,284
| -47% | -$21.7M | 0.01% | 1460 |
|
|
2020
Q4 | $52.5M | Sell |
833,411
-267,339
| -24% | -$16.6M | 0.02% | 1001 |
|
|
2020
Q3 | $74M | Buy |
1,100,750
+18,266
| +2% | +$997K | 0.03% | 760 |
|
|
2020
Q2 | $45.3M | Buy |
1,082,484
+152,380
| +16% | +$5.85M | 0.02% | 948 |
|
|
2020
Q1 | $29.3M | Buy |
930,104
+608,709
| +189% | +$24.4M | 0.01% | 1039 |
|
|
2019
Q4 | $13M | Sell |
321,395
-3,005
| -0.9% | -$105K | ﹤0.01% | 1624 |
|
|
2019
Q3 | $10.6M | Buy |
324,400
+85,000
| +36% | +$3.39M | ﹤0.01% | 1712 |
|
|
2019
Q2 | $11.6M | Buy |
+239,400
| New | +$10.2M | ﹤0.01% | 1687 |
|
Other funds holding SILK
Invesco's SILK Position: Q3 2024 in Review
Invesco sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 237,294 shares — an estimated $6.42M sold.
Invesco first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $74M in Q3 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Invesco reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Invesco sold 237,294 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $6.42M.
- Invesco first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Invesco's Silk Road Medical, Inc. Common Stock position peaked at $74M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.